ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $176,000 | -30.4% | 14,129 | -23.5% | 0.00% | -50.0% |
| Q3 2016 | $253,000 | +48.8% | 18,460 | -19.9% | 0.00% | +100.0% |
| Q2 2016 | $170,000 | +20.6% | 23,057 | +4.7% | 0.00% | 0.0% |
| Q1 2016 | $141,000 | +35.6% | 22,030 | +31.8% | 0.00% | 0.0% |
| Q4 2015 | $104,000 | -18.8% | 16,714 | -23.9% | 0.00% | 0.0% |
| Q3 2015 | $128,000 | +124.6% | 21,964 | +217.5% | 0.00% | – |
| Q2 2015 | $57,000 | +29.5% | 6,917 | +28.3% | 0.00% | – |
| Q1 2015 | $44,000 | +18.9% | 5,390 | +0.2% | 0.00% | – |
| Q4 2014 | $37,000 | +5.7% | 5,381 | -15.8% | 0.00% | – |
| Q3 2014 | $35,000 | -14.6% | 6,394 | 0.0% | 0.00% | – |
| Q2 2014 | $41,000 | -28.1% | 6,394 | -9.5% | 0.00% | -100.0% |
| Q1 2014 | $57,000 | +21.3% | 7,068 | +2.2% | 0.00% | – |
| Q4 2013 | $47,000 | -89.3% | 6,917 | -71.0% | 0.00% | -100.0% |
| Q3 2013 | $439,000 | +100.5% | 23,867 | +90.7% | 0.00% | +100.0% |
| Q2 2013 | $219,000 | – | 12,517 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |